Evidence map›Paper›PMID 26655797›Full record

ArticleMolecular systems biology2015

A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression.

Benjamin B Shields, Chad V Pecot, Hua Gao, Elizabeth McMillan, Malia Potts, Christa Nagel, Scott Purinton, Ying Wang, Cristina Ivan, Hyun Seok Kim and 9 more

Abstract read
In one paragraph

Article in Molecular systems biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Inhibition of miR-21 rescues liver regeneration after partial hepatectomy in ethanol-fed rats.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Benjamin B ShieldsDepartments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Chad V PecotCenter for RNA interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, TX, USA.
Hua GaoDepartments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Elizabeth McMillanDepartments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Malia PottsDepartments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Christa NagelObstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Scott PurintonObstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ying WangDepartment of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX, USA.
Cristina IvanDepartment of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX, USA.
Hyun Seok KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Robert J BorkowskiDepartments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Shaheen KhanImmunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Cristian Rodriguez-AguayoCenter for RNA interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, TX, USA.
Gabriel Lopez-BeresteinCenter for RNA interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, TX, USA.
Jayanthi LeaObstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Adi GazdarPathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Keith A BaggerlyDepartment of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX, USA.
Anil K SoodCenter for RNA interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, TX, USA.
Michael A WhiteDepartments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA michael.white@utsouthwestern.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCERP50CA083639 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C · 1999 to 2015
$33.0M
Texas Center for Cancer NanomedicineU54CA151668 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2010 to 2014
$12.4M
DIVISION OF CELL &MOLECULAR BIOLOGY TRAINING PROGRAMT32GM008203 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1987 to 2018
$7.0M
COMPONENTS OF RAS-MEDIATED GROWTH CONTROLR01CA071443 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 1996 to 2015
$4.8M
The RaLGTPase Regulatory NetworkR01CA129451 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 2007 to 2011
$1.3M
Targeting Mechanistic Subtypes of Neoplastic DiseaseR35CA197717 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 2015 to 2015
$725k
NCI NIH HHS CA129451NCI NIH HHS CA71443NCI NIH HHS P50 CA083639NCI NIH HHS P50CA083639NCI NIH HHS R01 CA071443NCI NIH HHS R01 CA129451NCI NIH HHS R35 CA197717NCI NIH HHS U54 CA151668NCI NIH HHS U54CA151668NIGMS NIH HHS T32 GM008203NIGMS NIH HHS T32-GM008203
6 · The paper itself

Abstract

Large-scale molecular annotation of epithelial ovarian cancer (EOC) indicates remarkable heterogeneity in the etiology of that disease. This diversity presents a significant obstacle against intervention target discovery. However, inactivation of miRNA biogenesis is commonly associated with advanced disease. Thus, restoration of miRNA activity may represent a common vulnerability among diverse EOC oncogenotypes. To test this, we employed genome-scale, gain-of-function, miRNA mimic toxicity screens in a large, diverse spectrum of EOC cell lines. We found that all cell lines responded to at least some miRNA mimics, but that the nature of the miRNA mimics provoking a response was highly selective within the panel. These selective toxicity profiles were leveraged to define modes of action and molecular response indicators for miRNA mimics with tumor-suppressive characteristics in vivo. A mechanistic principle emerging from this analysis was sensitivity of EOC to miRNA-mediated release of cell fate specification programs, loss of which may be a prerequisite for development of this disease.

Indexed as

AnimalsBiomimetic MaterialsCarcinoma, Ovarian EpithelialCell DifferentiationCell Line, TumorCell ProliferationCell SurvivalDown-RegulationFemaleGene Expression Regulation, NeoplasticGenome-Wide Association StudyHumansMiceMicroRNAsNeoplasms, Glandular and EpithelialOvarian NeoplasmsMicroRNAscancercancer geneticsmicroRNAmiRNAovarian cancer

Identifiers

PMID26655797
PMCPMC4704493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.